Cargando…
A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs
BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Heal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801220/ https://www.ncbi.nlm.nih.gov/pubmed/35106314 http://dx.doi.org/10.1093/ofid/ofab629 |
_version_ | 1784642405610291200 |
---|---|
author | Gelman, Stephanie S Stenehjem, Eddie Foster, Rachel A Tinker, Nick Grisel, Nancy Webb, Brandon J |
author_facet | Gelman, Stephanie S Stenehjem, Eddie Foster, Rachel A Tinker, Nick Grisel, Nancy Webb, Brandon J |
author_sort | Gelman, Stephanie S |
collection | PubMed |
description | BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Healthcare hospitals and a detoxification facility (DF) to provide simultaneous drug recovery assistance and parenteral antibiotic therapy (DRA-OPAT). METHODS: The CCDAI program was evaluated using a pre-/poststudy design. We compared outcomes in PWID hospitalized with SBI during a 1-year postimplementation period (2018) with similar patients from a historical control period (2017), identified by propensity modeling and manual review. RESULTS: Eighty-seven patients were candidates for the CCDAI program in the implementation period. Thirty-five participants (40.2%) enrolled in DRA-OPAT and discharged to the DF; 16 (45.7%) completed the full outpatient parenteral antibiotic therapy (OPAT) duration. Fifty-one patients with similar characteristics were identified as a preimplementation control group. Median length of stay (LOS) was reduced from 22.9 days (interquartile interval [IQI], 9.8–42.7) to 10.6 days (IQI, 6–17.4) after program implementation (P < .0001). Total median cost decreased from $39 220.90 (IQI, $23 300.71–$82 506.66) preimplementation to $27 592.39 (IQI, $18 509.45–$48 369.11) postimplementation (P < .0001). Ninety-day readmission rates were similar (23.5% vs 24.1%; P = .8). At 1-year follow-up, all-cause mortality was 7.1% in the preimplementation group versus 1.2% postimplementation (P = .06). CONCLUSIONS: Partnerships between hospitals and community resources hold promise for providing resource-efficient OPAT and drug recovery assistance. We observed significant reductions in LOS and cost without increases in readmission rates; 1-year mortality may have been improved. Further study is needed to optimize benefits of the program. |
format | Online Article Text |
id | pubmed-8801220 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88012202022-01-31 A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs Gelman, Stephanie S Stenehjem, Eddie Foster, Rachel A Tinker, Nick Grisel, Nancy Webb, Brandon J Open Forum Infect Dis Major Article BACKGROUND: Safe hospital discharge on parenteral antibiotic therapy is challenging for people who inject drugs (PWID) admitted with serious bacterial infections (SBI). We describe a Comprehensive Care of Drug Addiction and Infection (CCDAI) program involving a partnership between Intermountain Healthcare hospitals and a detoxification facility (DF) to provide simultaneous drug recovery assistance and parenteral antibiotic therapy (DRA-OPAT). METHODS: The CCDAI program was evaluated using a pre-/poststudy design. We compared outcomes in PWID hospitalized with SBI during a 1-year postimplementation period (2018) with similar patients from a historical control period (2017), identified by propensity modeling and manual review. RESULTS: Eighty-seven patients were candidates for the CCDAI program in the implementation period. Thirty-five participants (40.2%) enrolled in DRA-OPAT and discharged to the DF; 16 (45.7%) completed the full outpatient parenteral antibiotic therapy (OPAT) duration. Fifty-one patients with similar characteristics were identified as a preimplementation control group. Median length of stay (LOS) was reduced from 22.9 days (interquartile interval [IQI], 9.8–42.7) to 10.6 days (IQI, 6–17.4) after program implementation (P < .0001). Total median cost decreased from $39 220.90 (IQI, $23 300.71–$82 506.66) preimplementation to $27 592.39 (IQI, $18 509.45–$48 369.11) postimplementation (P < .0001). Ninety-day readmission rates were similar (23.5% vs 24.1%; P = .8). At 1-year follow-up, all-cause mortality was 7.1% in the preimplementation group versus 1.2% postimplementation (P = .06). CONCLUSIONS: Partnerships between hospitals and community resources hold promise for providing resource-efficient OPAT and drug recovery assistance. We observed significant reductions in LOS and cost without increases in readmission rates; 1-year mortality may have been improved. Further study is needed to optimize benefits of the program. Oxford University Press 2021-12-10 /pmc/articles/PMC8801220/ /pubmed/35106314 http://dx.doi.org/10.1093/ofid/ofab629 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Gelman, Stephanie S Stenehjem, Eddie Foster, Rachel A Tinker, Nick Grisel, Nancy Webb, Brandon J A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title | A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title_full | A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title_fullStr | A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title_full_unstemmed | A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title_short | A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs |
title_sort | novel program to provide drug recovery assistance and outpatient parenteral antibiotic therapy in people who inject drugs |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801220/ https://www.ncbi.nlm.nih.gov/pubmed/35106314 http://dx.doi.org/10.1093/ofid/ofab629 |
work_keys_str_mv | AT gelmanstephanies anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT stenehjemeddie anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT fosterrachela anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT tinkernick anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT griselnancy anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT webbbrandonj anovelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT gelmanstephanies novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT stenehjemeddie novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT fosterrachela novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT tinkernick novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT griselnancy novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs AT webbbrandonj novelprogramtoprovidedrugrecoveryassistanceandoutpatientparenteralantibiotictherapyinpeoplewhoinjectdrugs |